Depression and Pain Comorbidity: A Literature Review

Matthew Bair, Rebecca L. Robinson, Wayne Katon, Kurt Kroenke

Research output: Contribution to journalArticle

1797 Citations (Scopus)

Abstract

Because depression and painful symptoms commonly occur together, we conducted a literature review to determine the prevalence of both conditions and the effects of comorbidity on diagnosis, clinical outcomes, and treatment. The prevalences of pain in depressed cohorts and depression in pain cohorts are higher than when these conditions are individually examined. The presence of pain negatively affects the recognition and treatment of depression. When pain is moderate to severe, impairs function, and/or is refractory to treatment, it is associated with more depressive symptoms and worse depression outcomes (eg, lower quality of life, decreased work function, and increased health care utilization). Similarly, depression in patients with pain is associated with more pain complaints and greater impairment. Depression and pain share biological pathways and neurotransmitters, which has implications for the treatment of both concurrently. A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes.

Original languageEnglish
Pages (from-to)2433-2445
Number of pages13
JournalArchives of Internal Medicine
Volume163
Issue number20
DOIs
StatePublished - Nov 10 2003

Fingerprint

Comorbidity
Depression
Pain
Patient Acceptance of Health Care
Therapeutics
Neurotransmitter Agents
Quality of Life

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Depression and Pain Comorbidity : A Literature Review. / Bair, Matthew; Robinson, Rebecca L.; Katon, Wayne; Kroenke, Kurt.

In: Archives of Internal Medicine, Vol. 163, No. 20, 10.11.2003, p. 2433-2445.

Research output: Contribution to journalArticle

Bair, Matthew ; Robinson, Rebecca L. ; Katon, Wayne ; Kroenke, Kurt. / Depression and Pain Comorbidity : A Literature Review. In: Archives of Internal Medicine. 2003 ; Vol. 163, No. 20. pp. 2433-2445.
@article{0190e87529264cad9d7afba5d5a1ffa6,
title = "Depression and Pain Comorbidity: A Literature Review",
abstract = "Because depression and painful symptoms commonly occur together, we conducted a literature review to determine the prevalence of both conditions and the effects of comorbidity on diagnosis, clinical outcomes, and treatment. The prevalences of pain in depressed cohorts and depression in pain cohorts are higher than when these conditions are individually examined. The presence of pain negatively affects the recognition and treatment of depression. When pain is moderate to severe, impairs function, and/or is refractory to treatment, it is associated with more depressive symptoms and worse depression outcomes (eg, lower quality of life, decreased work function, and increased health care utilization). Similarly, depression in patients with pain is associated with more pain complaints and greater impairment. Depression and pain share biological pathways and neurotransmitters, which has implications for the treatment of both concurrently. A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes.",
author = "Matthew Bair and Robinson, {Rebecca L.} and Wayne Katon and Kurt Kroenke",
year = "2003",
month = "11",
day = "10",
doi = "10.1001/archinte.163.20.2433",
language = "English",
volume = "163",
pages = "2433--2445",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "20",

}

TY - JOUR

T1 - Depression and Pain Comorbidity

T2 - A Literature Review

AU - Bair, Matthew

AU - Robinson, Rebecca L.

AU - Katon, Wayne

AU - Kroenke, Kurt

PY - 2003/11/10

Y1 - 2003/11/10

N2 - Because depression and painful symptoms commonly occur together, we conducted a literature review to determine the prevalence of both conditions and the effects of comorbidity on diagnosis, clinical outcomes, and treatment. The prevalences of pain in depressed cohorts and depression in pain cohorts are higher than when these conditions are individually examined. The presence of pain negatively affects the recognition and treatment of depression. When pain is moderate to severe, impairs function, and/or is refractory to treatment, it is associated with more depressive symptoms and worse depression outcomes (eg, lower quality of life, decreased work function, and increased health care utilization). Similarly, depression in patients with pain is associated with more pain complaints and greater impairment. Depression and pain share biological pathways and neurotransmitters, which has implications for the treatment of both concurrently. A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes.

AB - Because depression and painful symptoms commonly occur together, we conducted a literature review to determine the prevalence of both conditions and the effects of comorbidity on diagnosis, clinical outcomes, and treatment. The prevalences of pain in depressed cohorts and depression in pain cohorts are higher than when these conditions are individually examined. The presence of pain negatively affects the recognition and treatment of depression. When pain is moderate to severe, impairs function, and/or is refractory to treatment, it is associated with more depressive symptoms and worse depression outcomes (eg, lower quality of life, decreased work function, and increased health care utilization). Similarly, depression in patients with pain is associated with more pain complaints and greater impairment. Depression and pain share biological pathways and neurotransmitters, which has implications for the treatment of both concurrently. A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes.

UR - http://www.scopus.com/inward/record.url?scp=0242455998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242455998&partnerID=8YFLogxK

U2 - 10.1001/archinte.163.20.2433

DO - 10.1001/archinte.163.20.2433

M3 - Article

C2 - 14609780

AN - SCOPUS:0242455998

VL - 163

SP - 2433

EP - 2445

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 20

ER -